Fever-Tree confident on FY25 outlook despite US tariffs
Fever-Tree has revealed it is trading in line with expectations for the year, boosted by strong early progress in the US market and continued leadership in the UK.
In an trading update today (5 June) ahead of the company’s AGM, the premium mixers brand said it continues to hold the top spot in both on- and off-trade channels, supported by a broadening drinks portfolio covering both alcoholic and non-alcoholic occasions.
In the US, it remains comfortable with current guidance for low single-digit group revenue growth and an adjusted EBITDA margin of around 12% for the 2025 financial year (FY25).
It said the business is already seeing a strong response in the US following the start of its strategic partnership with Molson Coors, which was announced in January.
Fever-Tree said the transition into Molson Coors’ distribution network is proceeding to plan and unlocking long-term growth opportunities.
“We are confident the brand will benefit from Molson Coors’ scale, including its deep customer relationships, merchandising capabilities, and supply chain,” the company said.
Subscribe to Grocery Gazette for free
Sign up here to get the latest grocery and food news each morning
However, across Europe, performance has been more mixed. The brand reports good momentum in France and the Netherlands, but softer sales in Germany. Growth continues to be led by its Ginger Beer line as Fever-Tree expands into new consumption occasions.
In the rest of the world, the company has begun local production in Australia, helping it to scale more efficiently and increase market share.
Fever-Tree also provided an update on the new 10% US tariff on UK imports, which will be shared equally with Molson Coors under the terms of their partnership.
The company said it is working to mitigate short-term impact, and expects the issue to ease longer term through onshoring of US production and a profit guarantee mechanism built into the agreement.
Meanwhile, as part of the transition, it brand announced that its CEO for North America, Charles Gibb, has stepped down following the handover to Molson Coors.
He is to be succeeded by Judd Hausner, Fever-Tree’s former US chief commercial officer, who brings experience from both Fever-Tree and the US beer sector.



